BioSpace News Archive

Ipsen and GENFIT announced that the U.S. Food and Drug Administration has accepted the New Drug Application for investigational elafibranor.

Spago Nanomedical AB announced that the first cancer patient has successfully been dosed in the clinical phase I/IIa study Tumorad-01 with the candidate drug 177Lu-SN201.

Regeneron Pharmaceuticals, Inc. announced the presentation of new and updated data on multiple combination therapies from its oncology pipeline at the European Society for Medical Oncology Immuno-Oncology Congress 2023 from December 6 to 8 in Geneva, Switzerland.

AudioCure Pharma GmbH announced that it has been awarded for its innovative compound AC102 by the Hearing Technology Innovator Awards™, honoring technological innovation and breakthroughs in the hearing industry.

United Therapeutics, a public benefit corporation, announced that the company has been named on Newsweek’s list of America’s Most Responsible Companies 2024.

Bristol Myers Squibb (NYSE: BMY) today announced that on December 6, 2023, its Board of Directors authorized the repurchase of an additional $3 billion of the company’s common stock under the company’s multi-year share repurchase program.

Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, announces First Patient First Visit (FPFV) in its Phase 2b RELIEF trial evaluating the potential of licaminlimab (also known as OCS-02), Oculis’ innovative anti-TNFα biologic eye drop, for the treatment of Dry Eye Disease (DED).

KalVista Pharmaceuticals, Inc . today provided an operational update and released financial results for the second fiscal quarter ended October 31, 2023.

Owens & Minor, Inc. has unveiled its new purpose, Life Takes Care. More than a motto or tagline, Life Takes Care captures the company’s unique approach to caring for both the business and the humanity at the heart of healthcare.

BD (Becton, Dickinson and Company) today announced it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.